BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 37234576)

  • 1. Erratum regarding missing Patient Consent statement in previously published articles.
    Trauma Case Rep; 2023 Jun; 45():100820. PubMed ID: 37234576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratum to Correct Informed Patient Consent Statement.
    Boro H; Sharma H; Mittal D; Pareek M; Chugh S; Singh Jakhar M; Nagar N; Bhatia L; Saini S; Joshi V; Vaid S; Mannar V; Nagendra L; Dalv M; Bundela V
    touchREV Endocrinol; 2024 Apr; 20(1):2. PubMed ID: 38812669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratum to the prognosis analysis of RFWD2 inhibiting the expression of ETV1 in colorectal cancer.
    Huang W; Tian X; Guan X
    Transl Cancer Res; 2020 Dec; 9(12):7809. PubMed ID: 35129550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum to clinicopathological and theranostic analysis of 82 breast cancer patients older than 80 years.
    Lv Q; Meng D; Sun C; Jin L; Xing C
    Transl Cancer Res; 2019 Apr; 8(2):713. PubMed ID: 35129546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum to lncRNA FAM66C inhibits pancreatic cancer progression by sponging miR-574-3p.
    Editorial Office
    Transl Cancer Res; 2024 Feb; 13(2):1221-1224. PubMed ID: 38482419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum to PAK4-relevant proliferation reduced by cell autophagy via p53/mTOR/p-AKT signaling.
    Editorial Office
    Transl Cancer Res; 2023 Oct; 12(10):2968-2969. PubMed ID: 37969396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum to atorvastatin inhibits pancreatic cancer cells proliferation and invasion likely by suppressing neurotrophin receptor signaling.
    Editorial Office
    Transl Cancer Res; 2023 Nov; 12(11):3220-3221. PubMed ID: 38130299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum to correlation among
    Li XF; Zhang TG; Zhang YX
    Transl Cancer Res; 2020 Oct; 9(10):6624. PubMed ID: 35129553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum to metformin up-regulated miR-107 expression and enhanced the inhibitory effect of miR-107 on gastric cancer growth.
    Chen Y; Gong W; Zhou Y; Fan R; Wu Y; Pei W; Sun S; Xu X; Jiang H
    Transl Cancer Res; 2020 Nov; 9(11):7381. PubMed ID: 35129547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum to survival outcomes of pancreaticoduodenectomy versus extended pancreaticoduodenectomy procedure for pancreatic head carcinoma: a propensity score matching study.
    Editorial Office
    Transl Cancer Res; 2023 Nov; 12(11):3218-3219. PubMed ID: 38130307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum to The targeting of endoglin on vascular endothelial cells affects the infiltration of M2 macrophages into the breast cancer microenvironment by modulating the interleukin-6 (IL-6) level.
    Editorial Office
    Transl Cancer Res; 2024 Feb; 13(2):1219-1220. PubMed ID: 38482407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum to MIER3 suppresses the progression of non-small cell lung cancer by inhibiting Wnt/β-Catenin pathway and histone acetyltransferase activity.
    Zhang H; Wang L; Bai J; Jiao W; Wang M
    Transl Cancer Res; 2020 Nov; 9(11):7379-7380. PubMed ID: 35129549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum for "Retraction statement: Prevalence of sexually transmitted infections and associated ‎risk behaviors in prisoners: A systematic review".
    Health Sci Rep; 2024 Jan; 7(1):e1851. PubMed ID: 38274139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum to "Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022" [Obes Pillars 2 (2022) 100018].
    Bays HE; Fitch A; Christensen S; Burridge K; Tondt J
    Obes Pillars; 2022 Dec; 4():100035. PubMed ID: 37990671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum to "Social consequences and genetics for the child with overweight and obesity: An obesity medicine association (OMA) clinical practice statement 2022" [Obes. Pillars 3 (2022) 100032].
    Cuda S; Censani M; Kharofa R; Williams DR; O'Hara V; Karjoo S; Paisley J; Browne NT
    Obes Pillars; 2022 Dec; 4():100037. PubMed ID: 37990667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum to "Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials" [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233].
    Hollander BD; Rothuizen-Lindenschot M; Geertjens L; Vaz FM; Brands MM; Le HL; van Eeghen AM; van de Ven PM; Cornel MC; Jacobs BAW; Bruining H; van Karnebeek CD
    Contemp Clin Trials Commun; 2024 Apr; 38():101264. PubMed ID: 38533474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to "Nutritional and activity recommendations for the child with normal weight, overweight, and obesity with consideration of food insecurity: An Obesity Medical Association (OMA) Clinical Practice Statement 2022" [Obesity Pillars 2 (2022) 100012].
    Browne NT; Cuda SE
    Obes Pillars; 2022 Dec; 4():100036. PubMed ID: 37990665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum:  Correction to "Complicated appendicitis, acute pancreatitis, pleural effusion, and sinus bradycardia in a COVID-19 patient".
    Clin Case Rep; 2023 Sep; 11(9):e7493. PubMed ID: 37767144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum: Case Report: application of morphology in the diagnosis of siderosis in a patient with tuberculosis infection.
    Frontiers Production Office
    Front Oncol; 2023; 13():1281636. PubMed ID: 37823057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum: A Revised PADMA Scoring System for Predicting in-Hospital Mortality in Acute Coronary Syndrome Patient [Corrigendum].
    Int J Gen Med; 2023; 16():5289-5290. PubMed ID: 38021041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.